APA stil citiranja

Profozić, V., Mrzljak, V., Nazar, I., Metelko, Ž., Rosenkranz, B., Lange, C., & Malerczyk, V. (1999). Safety, efficacy, and pharmacokinetics of glimepiride in diabetic patients with renal impairment over a 3-month period: Safety, efficacy, and pharmacokinetics of glimepiride in diabetic patients with renal impairment over a 3-month period. Diabetologia Croatica, p. 8.

Chicago stil citiranja

Profozić, Velimir, Vladimir Mrzljak, Ines Nazar, Željko Metelko, Bernd Rosenkranz, Claudia Lange, and Vitus Malerczyk. "Safety, efficacy, and pharmacokinetics of glimepiride in diabetic patients with renal impairment over a 3-month period: Safety, efficacy, and pharmacokinetics of glimepiride in diabetic patients with renal impairment over a 3-month period." 1999: 8.

MLA stil citiranja

Profozić, Velimir, et al. "Safety, efficacy, and pharmacokinetics of glimepiride in diabetic patients with renal impairment over a 3-month period: Safety, efficacy, and pharmacokinetics of glimepiride in diabetic patients with renal impairment over a 3-month period." 1999: 8.